Strategic Pharma Sourcing

Safeguarding neuromedication availability through AI-driven intelligence.

Itera bridges the gap between global supply chain data and the local need for critical neuromedication and Active Pharmaceutical Ingredients (API). We find the route to availability where others get stuck.

Discover our methodology Get in touch

120+: API source countries monitored
EU-27: Regulatory coverage
24/7: Signal detection

HubCritical signalAt-risk route

Problem & Solution

The chain is fragile, we make it predictable.

The problem

Shortages are increasing.

The pharmaceutical chain is fragile. Shortages in psychiatry and broader healthcare are increasing due to a lack of real-time visibility into complex global supply chains, from API production to local distribution.

Concentration of API production in a few regions
No transparency on upstream bottlenecks
Fragmented EU registrations and marketing authorizations
Reactive instead of predictive procurement

Our solution

Predict, source, deliver.

Itera combines domain expertise in chemistry and regulation with advanced algorithms to predict and resolve shortages through strategic sourcing, before a shortage reaches the patient.

Real-time signal detection at API and logistics level
EU-wide regulatory mapping and alternative routes
Strategic sourcing through verified partners
Robust inventory infrastructure for institutions

Split brain visualisation: analytical wireframe meets supply chain network with a single critical signal

CNS focus

Two hemispheres, one mission.

On the left, the clinical reality of neuropsychiatric care. On the right, a living network of API producers, regulators and logistics routes. Itera connects the two, and the moment a single node turns red, we are already routing around it.

Our pillars

Three disciplines, one outcome: availability.

Supply Chain Intelligence

Real-time monitoring of global API (Active Pharmaceutical Ingredients) production and logistics flows, for early detection of bottlenecks.

Regulatory Mapping

Identification of unused marketing authorizations and alternative registration routes within the EU, including Art. 126a.

Resilience Orchestration

Building robust infrastructure for healthcare institutions and wholesalers to secure inventory.

Technology

Powered by Agentic AI.

Together with leading technology partners we develop autonomous workflows that translate unstructured market signals into concrete sourcing actions, from regulatory documents to logistics fluctuations.

Autonomous signal-to-action workflows

Multi-source document intelligence

EU regulatory knowledge graph

Human-in-the-loop sourcing review

agent.itera.workflowlive

01
Signal detected
API shortage risk · Beta-blocker class · IN cluster
02
Mapping registrations
EU Art. 126a · 4 dormant licenses identified
03
Sourcing route
Verified MAH · DE → NL · ETA 11 days
04
Action proposal
Awaiting partner review

Strategic partnerships

Who we build availability with.

Manufacturers

Optimizing distribution within the EU and unlocking new sales channels through verified partners.

Governments & Institutions

Strategic inventory management of critical neuromedication and risk reduction at national and regional level.

License Holders

Activating dormant dossiers and leveraging existing marketing authorizations under Art. 126a.

Make your supply chain resilient.

Schedule a confidential conversation with our sourcing team. We review your critical SKU portfolio and identify concrete continuity risks.

Schedule a call